Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 14, 2022 04:48 ET | Source: Research and Markets

Asia Cervical Cancer Test (Screening) Market Report 2022: Market will Reach $4.5 Billion by 2027 from $3.6 Billion in 2021

Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Asia Cervical Cancer Test (Screening) Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19" report has been added to...
February 10, 2022 04:13 ET | Source: Research and Markets

The Global Women's Health Diagnostics Market is Expected to Register a CAGR of 7.5% Between 2021 and 2026

Dublin, Feb. 10, 2022 (GLOBE NEWSWIRE) -- The "Women's Health Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecast (2021 - 2026)" report has been added to ResearchAndMarkets.com's...
December 13, 2021 04:18 ET | Source: Research and Markets

United States and Canada Cervical Cancer Screening Industry Forecast to Reach US$ 8.2 Billion by 2027

Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "United States and Canada Cervical Cancer Screening Market, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Company Analysis" report has been...
August 25, 2021 08:48 ET | Source: Research and Markets

World Cervical Cancer Diagnostics Market Research Report 2021: Focus on Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical Curettage

Dublin, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The "Cervical Cancer Diagnostics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. ...
February 18, 2021 07:58 ET | Source: Research and Markets

Global Women’s Health Diagnostics Market Report 2021 - Market is Projected to Reach $36.6 Billion by 2025 from $25.0 Billion in 2020

Dublin, Feb. 18, 2021 (GLOBE NEWSWIRE) -- The "Women's Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis,...
February 08, 2021 04:18 ET | Source: Research and Markets

Cervical Cancer Screening Market, 2026 - Patients, Mortality Forecast by Tests Type -Pap Smear, HPV DNA, VIA

Dublin, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The "Cervical Cancer Screening Market, Patients, Mortality Global Forecast by Tests Type (Pap Smear, HPV DNA, VIA), 19 Countries Analysis" report has been...
December 24, 2020 05:18 ET | Source: Research and Markets

Global Cervical Cancer Diagnostic Testing Devices Pipeline Assessment 2020: Developments, Products, Company Product Overview, Recent Developments

Dublin, Dec. 24, 2020 (GLOBE NEWSWIRE) -- The "Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering. "Cervical...
December 22, 2020 05:58 ET | Source: Research and Markets

Global Cervical Cancer Diagnostics Market Report 2020: Market is Expected to Recover and Reach $8.62 Billion in 2023 at a CAGR of 6.04%

Dublin, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The "Cervical Cancer Diagnostics Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. ...
June 20, 2013 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Signs Distribution Agreement With Fisher HealthCare

SEATTLE, WA--(Marketwired - Jun 20, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, has signed an agreement with Fisher HealthCare Inc., part of Thermo Fisher...
June 10, 2013 08:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Supports Are You Dense, Inc. and Its Work to Enact Dense Breast Notification Laws

SEATTLE, WA--(Marketwired - Jun 10, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, today announced its support for Are You Dense, Inc., an independent, national...